UBS O'Connor’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Sell |
21,892
-4,901
| -18% | -$206K | 0.05% | 212 |
|
|
2025
Q1 | $1.01M | Buy |
26,793
+290
| +1% | +$11K | 0.03% | 174 |
|
|
2024
Q4 | $2.04M | Sell |
26,503
-11,987
| -31% | -$923K | 0.05% | 152 |
|
|
2024
Q3 | $2.21M | Buy |
38,490
+2,761
| +8% | +$159K | 0.05% | 153 |
|
|
2024
Q2 | $1.48M | Buy |
35,729
+1,000
| +3% | +$41.4K | 0.04% | 234 |
|
|
2024
Q1 | $2.12M | Buy |
34,729
+12,451
| +56% | +$760K | 0.06% | 160 |
|
|
2023
Q4 | $496K | Sell |
22,278
-16,625
| -43% | -$370K | 0.02% | 341 |
|
|
2023
Q3 | $998K | Hold |
38,903
| – | – | 0.02% | 324 |
|
|
2023
Q2 | $671K | Buy |
38,903
+5,086
| +15% | +$87.7K | 0.01% | 413 |
|
|
2023
Q1 | $410K | Buy |
+33,817
| New | +$410K | 0.01% | 461 |
|
|
2022
Q4 | – | Sell |
-7,718
| Closed | -$263K | – | 239 |
|
|
2022
Q3 | $263K | Sell |
7,718
-6,667
| -46% | -$227K | ﹤0.01% | 802 |
|
|
2022
Q2 | $529K | Buy |
+14,385
| New | +$529K | 0.01% | 792 |
|